Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-10 Sale | 2024-07-12 5:46 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 12,923 | $22.49 | $290,598 | 1,773,300 (Direct) | View |
| 2024-06-24 Sale | 2024-06-26 5:07 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 12,930 | $23.1 | $298,711 | 1,636,223 (Direct) | View |
| 2024-02-08 Sale | 2024-02-12 8:22 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 92,001 | $27.13 | $2,495,822 | 1,059,153 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:59 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 5,696 | $18.41 | $104,851 | 1,151,154 (Direct) | View |
| 2023-12-15 Sale | 2024-01-08 4:19 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 102,303 | $19.15 | $1,959,354 | 1,156,850 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:56 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 34,446 | $20.61 | $709,873 | 1,859,153 (Direct) | View |
| 2023-01-19 Sale | 2023-01-23 7:57 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 19,524 | $20.1 | $392,474 | 1,893,599 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 5:56 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer 10% Owner | 86,877 | $23.23 | $2,018,344 | 1,913,123 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-10 Exercise | 2024-07-12 5:46 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 1,270 | $15.78 | 1,773,300 (Direct) | View |
| 2024-07-10 Exercise | 2024-07-12 5:46 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 12,923 | $0 | 1,773,300 (Direct) | View |
| 2024-07-10 Exercise | 2024-07-12 5:46 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 11,653 | $14.42 | 1,773,300 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-26 5:07 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 12,930 | $0 | 1,636,223 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-26 5:07 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 12,930 | $14.42 | 1,636,223 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 590,000 | $0 | 590,000 (Direct) | View |
| 2023-05-02 Gift | 2023-05-04 8:09 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 600,000 | $0 | 1,859,153 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:24 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 222,000 | $0 | 222,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:40 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer 10% Owner | 150,000 | $0 | 2,150,000 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:05 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2020-12-10 7:15 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks 10% Owner | 0 | $0 | 2,000,000 (Direct) | View |